Contents |
1 |
The Pharmacology of Muscarinic Receptors |
1.1 |
Introduction |
1.2 |
Muscarinic receptor subtypes |
2 |
Pharmacological Effects of Agonists and Therapeutic Applications |
2.1 |
Cardiovascular system |
2.2 |
Gastointestinal tract |
2.3 |
Other smooth muscle |
2.4 |
Glandular secretions |
2.5 |
The eye |
2.6 |
Central nervous system |
|
|
3 |
Pharmacological Effects of Antagonists and Therapeutic Applications |
3.1 |
Introduction |
3.2 |
Cardiovascular system |
3.3 |
Gastrointestinal tract |
3.4 |
Urinary bladder |
3.5 |
Airways |
3.6 |
The eye |
3.7 |
Prostate gland |
|
|
4 |
The Medicinal Chemistry of Muscarinic Receptor Agonists and Antagonists |
4.1 |
Scope |
|
|
5 |
Muscarinic Agonists |
5.1 |
Arecoline |
5.2 |
Heterocyclic and other derivatives of arecoline |
5.3 |
The synthesis of 1-aza-bicyclo[2.2.1]heptanes (1-azanorbornanes) and 1-azabicyclo[2.2.2]octanes (quinuclidines) |
5.3.1 |
Intramolecular nucleophilic displacement by amines |
5.3.2 |
Dieckmann condensation |
5.3.3 |
Ester surrogates |
|
|
6 |
Muscarinic Antagonists |
6.1 |
Enantioselective synthesis of tertiary centres; tolterodine, rociverine, IQNP |
6.2 |
Diels-Alder reactions |
6.2.1 |
Indole alkaloids; allosteric activators of muscarinic binding |
6.2.2 |
Himbacine; a muscarinic antagonist with allosteric properties |
6.2.3 |
Cyclostellettamines; macrocyclic muscarinic antagonists |
|
|
7 |
Conclusions and Future Prospects |
8 |
References |